Comments
Loading...

Acrivon Therapeutics Short Interest Report

ACRVNASDAQ
Logo brought to you by Benzinga Data
Q1 2025 Earnings were released on Wed May 14th, before the market open

Acrivon Therapeutics Stock Short Interest Report | NASDAQ:ACRV | Benzinga

Short interest in Acrivon Therapeutics Inc (NASDAQ:ACRV) increased during the last reporting period, rising from 710.51K to 1.39M. This put 11.87% of the company's publicly available shares short.

Short interest in Acrivon Therapeutics Corp (XNAS:ACRV) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.

Based on the recent average volume of 2.04M shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.

Short Interest
1.39M
Short Interest %
11.9%
Days to Cover
1
Get Alert
ACRVAcrivon Therapeutics, Inc. Com04/30/202505/09/202511.87%11,746,3241,393,7202,036,6711Get Alert
ACRVAcrivon Therapeutics, Inc. Com04/15/202504/25/20255.94%11,960,146710,505371,5621.91Get Alert
ACRVAcrivon Therapeutics, Inc. Com03/31/202504/09/20257.42%11,960,146887,113300,7012.95Get Alert
ACRVAcrivon Therapeutics, Inc. Com03/14/202503/25/20256.11%11,960,146730,57423,96630.48Get Alert
ACRVAcrivon Therapeutics, Inc. Com02/28/202503/11/20256.26%11,960,146748,67655,46213.5Get Alert
ACRVAcrivon Therapeutics, Inc. Com02/14/202502/26/20259.47%11,960,1461,132,370105,54610.73Get Alert
ACRVAcrivon Therapeutics, Inc. Com01/31/202502/11/20259.18%11,960,1461,098,40732,17734.14Get Alert
ACRVAcrivon Therapeutics, Inc. Com01/15/202501/27/20259.75%11,960,1461,166,07440,69028.66Get Alert
ACRVAcrivon Therapeutics, Inc. Com12/31/202401/10/20259.84%11,960,1461,177,14758,38420.16Get Alert
ACRVAcrivon Therapeutics, Inc. Com12/13/202412/24/20249.25%11,960,1461,105,72864,65217.1Get Alert
ACRVAcrivon Therapeutics, Inc. Com11/29/202412/10/20249.31%11,960,1461,113,71142,15126.42Get Alert
ACRVAcrivon Therapeutics, Inc. Com11/15/202411/26/20249.29%11,960,1461,111,31753,13120.92Get Alert
ACRVAcrivon Therapeutics, Inc. Com10/31/202411/11/20249.15%11,796,0131,079,22047,88222.54Get Alert
ACRVAcrivon Therapeutics, Inc. Com10/15/202410/24/20249.43%11,796,0131,112,30989,08912.49Get Alert
ACRVAcrivon Therapeutics, Inc. Com09/30/202410/09/202410.23%11,796,0131,207,265185,9056.49Get Alert
ACRVAcrivon Therapeutics, Inc. Com09/13/202409/24/202410.88%11,796,0131,282,95181,43315.75Get Alert
ACRVAcrivon Therapeutics, Inc. Com08/30/202409/11/20248.71%11,796,0131,026,97666,82215.37Get Alert
ACRVAcrivon Therapeutics, Inc. Com08/15/202408/26/20248.59%11,796,0131,013,00656,69717.87Get Alert
ACRVAcrivon Therapeutics, Inc. Com07/31/202408/09/20248.83%11,700,7821,033,11162,30716.58Get Alert
ACRVAcrivon Therapeutics, Inc. Com07/15/202407/24/20249.12%11,700,7821,067,680125,0528.54Get Alert
ACRVAcrivon Therapeutics, Inc. Com06/28/202407/10/20249.80%11,700,7821,146,469169,4636.77Get Alert
ACRVAcrivon Therapeutics, Inc. Com06/14/202406/26/20248.89%11,700,7821,040,29496,62710.77Get Alert
ACRVAcrivon Therapeutics, Inc. Com05/31/202406/11/20248.83%11,700,7821,033,19878,10613.23Get Alert
ACRVAcrivon Therapeutics, Inc. Com05/15/202405/24/20249.01%11,700,7821,053,682159,6396.6Get Alert
ACRVAcrivon Therapeutics, Inc. Com04/30/202405/09/20249.27%11,699,3061,084,449339,1503.2Get Alert
ACRVAcrivon Therapeutics, Inc. Com04/15/202404/24/20248.77%11,699,3061,025,5223,689,8121Get Alert
ACRVAcrivon Therapeutics, Inc. Com03/28/202404/09/20243.65%14,608,502532,96169,0047.72Get Alert
ACRVAcrivon Therapeutics, Inc. Com03/15/202403/26/20243.42%14,165,858484,038108,4494.46Get Alert
ACRVAcrivon Therapeutics, Inc. Com02/29/202403/11/20242.79%14,165,858394,61671,3525.53Get Alert
ACRVAcrivon Therapeutics, Inc. Com02/15/202402/27/20242.63%14,165,858372,65394,3133.95Get Alert
ACRVAcrivon Therapeutics, Inc. Com01/31/202402/09/20242.32%14,165,858328,02036,4319Get Alert
ACRVAcrivon Therapeutics, Inc. Com01/12/202401/24/20242.32%14,165,858327,96675,4304.35Get Alert
ACRVAcrivon Therapeutics, Inc. Com12/29/202301/10/20242.24%14,165,858316,64728,48711.12Get Alert
ACRVAcrivon Therapeutics, Inc. Com12/15/202312/27/20232.07%14,165,858293,52648,0026.11Get Alert
ACRVAcrivon Therapeutics, Inc. Com11/30/202312/11/20232.00%14,165,858283,36023,00112.32Get Alert
ACRVAcrivon Therapeutics, Inc. Com11/15/202311/27/20232.05%14,165,858290,21525,65411.31Get Alert
ACRVAcrivon Therapeutics, Inc. Com10/31/202311/09/20232.19%14,044,467307,62923,98012.83Get Alert
ACRVAcrivon Therapeutics, Inc. Com10/13/202310/24/20232.17%14,044,467304,92920,16415.12Get Alert
ACRVAcrivon Therapeutics, Inc. Com09/29/202310/10/20232.26%14,044,467317,7696,70247.41Get Alert
ACRVAcrivon Therapeutics, Inc. Com09/15/202309/26/20232.30%14,044,467322,63418,41917.52Get Alert
ACRVAcrivon Therapeutics, Inc. Com08/31/202309/12/20232.30%14,044,467322,7328,89036.3Get Alert
ACRVAcrivon Therapeutics, Inc. Com08/15/202308/24/20232.36%14,044,467332,09612,94125.66Get Alert
ACRVAcrivon Therapeutics, Inc. Com07/31/202308/09/20232.42%13,897,533335,98617,17619.56Get Alert
ACRVAcrivon Therapeutics, Inc. Com07/14/202307/25/20232.49%13,897,533346,25811,66829.68Get Alert
ACRVAcrivon Therapeutics, Inc. Com06/30/202307/12/20232.61%13,897,533362,54556,8746.37Get Alert
ACRVAcrivon Therapeutics, Inc. Com06/15/202306/27/20232.59%13,897,533359,97126,96613.35Get Alert
ACRVAcrivon Therapeutics, Inc. Com05/31/202306/09/20232.74%13,897,533380,88921,21217.96Get Alert
ACRVAcrivon Therapeutics, Inc. Com05/15/202305/24/20232.93%13,897,533406,59626,81715.16Get Alert

Looking for the most shorted stocks?

People Also Watch